Posted inWorld

Preparing for a world with Alzheimer’s treatment

When the US Food and Drug Administration approved Alzheimer’s drug aducanumab in June 2021 — against the advice of its own expert committee — it triggered much hand-wringing in the research and medical community. One group of Australian experts likened the drugmaker’s approval by the FDA to “winning a Texas sharpshooter contest by drawing a bullseye around a bullet […]